A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
M.D. Anderson Cancer Center
University of California, Irvine
Duke University
Essen Biotech
Essen Biotech
Nanjing Sanhome Pharmaceutical, Co., Ltd.
DualityBio Inc.
Takeda
Second Life Therapeutics
University Health Network, Toronto
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Coherus Oncology, Inc.
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
7 Hills Pharma, LLC
Washington University School of Medicine
Milton S. Hershey Medical Center
Novita Pharmaceuticals, Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Columbia University
Tvardi Therapeutics, Incorporated
Aptamer Sciences, Inc.
Intensity Therapeutics, Inc.
Centre Georges Francois Leclerc
Alliance for Clinical Trials in Oncology
Changhai Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
University of Chicago
NantBioScience, Inc.
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Comprehensive Support Project for Oncology Research
Pfizer
Celldex Therapeutics
Zhejiang University
Fusion Pharmaceuticals Inc.
Massachusetts General Hospital
Massachusetts General Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Klus Pharma Inc.
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology